CT/MR LI-RADS 2018: clinical implications and management recommendations.
Publication/Presentation Date
4-1-2019
Abstract
Unique among solid organ tumors, hepatocellular carcinoma (HCC), may be diagnosed by imaging alone, without the need for biopsy. The Liver Imaging Reporting and Data System (LI-RADS) was developed to provide high-specificity diagnosis of HCC based on imaging while also standardizing the assessment and reporting of the entire spectrum of lesions and pseudolesions encountered in patients at risk for this malignancy. In this pictorial review, we discuss management recommendations associated with CT/MR LI-RADS observations. We emphasize the rationale for the recommendations and the role of multidisciplinary management discussion, and we provide a framework for standardized reporting. Management of patients who undergo ultrasound (US) for screening and surveillance or those who undergo diagnostic contrast-enhanced ultrasound (CEUS) is beyond the scope of this paper.
Volume
44
Issue
4
First Page
1306
Last Page
1322
ISSN
2366-0058
Published In/Presented At
Kamath, A., Roudenko, A., Hecht, E., Sirlin, C., Chernyak, V., Fowler, K., & Mitchell, D. G. (2019). CT/MR LI-RADS 2018: clinical implications and management recommendations. Abdominal radiology (New York), 44(4), 1306–1322. https://doi.org/10.1007/s00261-018-1868-6
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
30671612
Department(s)
Administration and Leadership
Document Type
Article